Saks Samuel R 4
4 · PDL BIOPHARMA, INC. · Filed Jun 12, 2018
Insider Transaction Report
Form 4
Saks Samuel R
Director
Transactions
- Award
Common stock
2018-06-08$2.76/sh+54,348$150,000→ 214,190 total
Footnotes (1)
- [F1]The grant will cliff-vest on the first anniversary of the date of grant so long as the grant recipient continues to serve on the Board of Directors of PDL BioPharma, Inc.